MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1086/653115

Медицинская библиотека · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2010

Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis.

Jacobson Karen R, Tierney Dylan B, Jeon Christie Y, Mitnick Carole D, Murray Megan B

СтатьяМетаанализПоддержка NIH: внешняя программаСистематический обзорПеревод в очереди

Аннотация

BACKGROUND

. The treatment of extensively drug-resistant tuberculosis (XDR TB) presents a major challenge. Second-line antimycobacterial drugs are less effective, more toxic, and more costly than first-line agents, and XDR TB strains are, by definition, resistant to the most potent second-line options: the injectable agents and fluoroquinolones. We conducted a meta-analysis to assess XDR TB treatment outcomes and to identify therapeutic approaches associated with favorable responses.

METHODS

We searched PubMed and EMBASE databases to identify studies conducted through May 2009 that report XDR TB treatment outcomes.

RESULTS

The search yielded 13 observational studies covering 560 patients, of whom 43.7% (95% confidence interval, 32.8%-54.5%) experienced favorable outcomes, defined as either cure or treatment completion, and 20.8% (95% confidence interval, 14.2%-27.3%) died. Random effects meta-analysis and meta-regression showed that studies in which a higher proportion of patients received a later-generation fluoroquinolone reported a higher proportion of favorable treatment outcomes (P=.012).

CONCLUSIONS

This meta-analysis provides the first empirical evidence that the use of later-generation fluoroquinolones for the treatment of XDR TB significantly improves treatment outcomes, even though drug-susceptibility testing demonstrates resistance to a representative fluoroquinolone. These results suggest that the addition of later-generation fluoroquinolones to XDR TB regimens may improve treatment outcomes and should be systematically evaluated in well-designed clinical studies.

Для цитирования: Jacobson Karen R, Tierney Dylan B, Jeon Christie Y, Mitnick Carole D, Murray Megan B. Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2010. DOI: 10.1086/653115.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.